Table 1.
Socio-demographic and clinical profile of patients with DR-TB and DS-TB who were enrolled in the Zimbabwe patient cost survey, 2018
| Characteristic | DR-TB | DS-TB | Total | |||
|---|---|---|---|---|---|---|
|
|
||||||
| N | (%) | n | (%) | n | (%) | |
| 49 | (6) | 851 | (94) | 900‡ | ||
| Sex | ||||||
| Male | 28 | (56) | 472 | (56) | 500 | (56) |
| Female | 21 | (44) | 379 | (44) | 400 | (44) |
| Age group (years) | ||||||
| <15 | 0 | (0) | 52 | (6) | 52 | (6) |
| 15-24 | 4 | (8) | 99 | (12) | 103 | (12) |
| 25-34 | 21 | (42) | 209 | (24) | 230 | (26) |
| 35-44 | 15 | (31) | 277 | (33) | 292 | (33) |
| 45-54 | 7 | (14) | 124 | (15) | 131 | (15) |
| 55-64 | 0 | (0) | 53 | (6) | 53 | (6) |
| ≥65 | 2 | (5) | 37 | (4) | 39 | (4) |
| Mean (SD) | 36.4 | (11.9) | 36.9 | (14.8) | 36.9 | (14.7) |
| Treatment phase | ||||||
| Intensive | 17 | (34) | 376 | (44) | 392 | (44) |
| Continuation | 32 | (66) | 475 | (56) | 508 | (56) |
| HIV Status | ||||||
| Positive | 35 | (72) | 522 | (61) | 557 | (62) |
| Negative | 14 | (28) | 321 | (38) | 335 | (37) |
| Unknown | 0 | (0) | 8 | (1) | 8 | (1) |
| Type of TB patient | ||||||
| New | 45 | (91) | 796 | (94) | 841 | (94) |
| Retreatment | 4 | (9) | 55 | (6) | 59 | (6) |
| Facility location | ||||||
| Urban | 34 | (69) | 506 | (59) | 540 | (60) |
| Rural | 15 | (31) | 345 | (41) | 360 | (40) |
‡
=weighted sample size;
DR-TB=drug resistant TB; DS-TB=drug susceptible TB; SD=Standard deviation; HIV = Human Immunodeficiency Virus